Skip to main content

Conduent Announces COVID-19 Vaccine Response Solutions for Public Health Agencies

Multi-pronged offering helps agencies solve critical challenges with vaccine rollout, efficiency and reach through public awareness, eligibility support, appointments and post-immunization follow-up
Public health agencies can leverage robust community outreach and constituent support capabilities to assist in COVID-19 vaccine managementFLORHAM PARK, N.J., March 16, 2021 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a business process services and solutions company, today introduced a new set of offerings designed for U.S. public health agencies to overcome a range of challenges in administering COVID-19 vaccines effectively and efficiently. Now underway with more than 109 million doses administered to date, the national COVID-19 vaccine rollout is among the largest vaccine programs administered in the history of public health, affecting more than 300 million Americans.In addition to the operational challenges of a national immunization program, state and local health officials have faced an influx of questions from community members about the vaccine itself – from concerns over how the vaccine is administered to potential side effects and how it will affect them long term. To address these concerns, public health agencies need robust community outreach and constituent support programs.“Agencies across the country are navigating the very complex administration of the COVID-19 vaccine,” said Cliff Skelton, President and CEO at Conduent. “The enormous scale of this initiative requires a rapidly deployed and flexible set of solutions to provide inbound and outbound vaccine information to recipients as efficiently as possible. With our strong eligibility assessment and determination experience, as well as customer contact services and outreach expertise, we’re proud to offer these services to agencies at such a critical time.”Core Features of Vaccine Response Solutions:
To help agencies manage a variety of important programs and accelerate the immunization process, Conduent’s offering has five key solutions:
Managing helplines and customer support services to centralize information about the vaccine and address people’s concerns and reservationsEducating and engaging communities about COVID-19 vaccine availability and resources, including outreach to individuals lacking mobility, phone or internet accessAssisting with screening individuals for clinical eligibility for COVID-19 vaccines, leveraging existing case management toolsSetting vaccine appointments and providing reminders about designated dates and locations, and then alerting individuals about their second doseOffering post-vaccination follow-ups to track patient wellbeing after vaccination, and to measure and mitigate adverse reactions
“These offerings are a natural extension of our government healthcare and pharmacy benefit management solutions,” Skelton continued. “With more than 50 years of government health and social services support experience, our team stands ready to support agencies in their public health response to benefit citizens.”Depending upon client requirements, Conduent estimates these solutions can typically be implemented in as few as two to four weeks. More information about Conduent’s Vaccine Response Solutions can be found here.Conduent supports more than 41 million consumers annually with various government health programs and other eligibility services. These include government health care programs in 24 states, plus Washington, D.C., and Puerto Rico. In addition, Conduent provides public health agencies with its Maven® disease surveillance and outbreak management software, which is used to track and report cases of COVID-19 and other diseases.About Conduent
Conduent delivers mission-critical services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through process, technology and our diverse and dedicated associates, Conduent solutions and services automate workflows, improve efficiencies, reduce costs and enable revenue growth. It’s why most Fortune 100 companies and over 500 government entities depend on Conduent every day to manage their essential interactions and move their operations forward.
Conduent’s differentiated services and solutions improve experiences for millions of people every day, including three out of every four U.S. insured patients, 10 million employees who use its HR Services, and nearly 18 million benefits recipients. Conduent’s solutions deliver exceptional outcomes for its clients including $16 billion in savings from medical bill review of workers compensation claims, up to 40% efficiency increase in HR operations, up to 27% reduction in government benefits costs, up to 40% improvement in finance, accounting and procurement expense, and improved customer service interaction times by up to 20% with higher end-user satisfaction. Learn more at https://www.conduent.com.Media Contacts:
Neil Franz, Conduent, +1-301-820-4324, neil.franz@conduent.com
Investor Relations Contacts:
Alan Katz, Conduent, +1-973-526-7173, alan.katz@conduent.com
Rebecca Koar, Conduent, +1-862-308-7105, rebecca.koar@conduent.com
Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.Conduent is a trademark of Conduent Incorporated in the United States and/or other countries.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.